Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Servier
Servier
University of Alabama at Birmingham
Columbia University
Fore Biotherapeutics
New York Medical College
St. Jude Children's Research Hospital
Vanderbilt University Medical Center
Columbia University